Form 4: Dexcom EVP Jereme M. Sylvain Sells Shares to Cover Tax Obligations
SEC Form 4
Jereme M. Sylvain, EVP and Chief Financial Officer of Dexcom Inc., sold 746 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On September 9, 2024, Jereme M. Sylvain, the EVP and Chief Financial Officer of Dexcom Inc. (DXCM), sold 746 shares of Dexcom's common stock.
- The sale was executed at a price of $69.15 per share.
- This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Sylvain directly owns 84,274 shares of Dexcom, which includes 49,085 unvested restricted stock units granted on various dates and 72 shares acquired under the Employee Stock Purchase Plan on August 30, 2024.
Sentiment
Score: 6
Explanation: The document is neutral, reporting a routine transaction related to executive compensation. It doesn't indicate positive or negative sentiment towards the company's performance.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. The sale itself is unlikely to have a significant impact on Dexcom's stock price, as it is related to tax obligations and not a discretionary trade.
Key Dates
| Date | Description |
|---|---|
| December 15, 2021 | Grant date of 1,460 restricted stock units which shall vest through December 15, 2024 |
| March 8, 2022 | Grant date of 7,060 restricted stock units which shall vest through March 8, 2025 |
| March 8, 2023 | Grant date of 14,512 restricted stock units which shall vest through March 8, 2026 |
| March 8, 2024 | Grant date of 26,053 restricted stock units which shall vest through March 8, 2027 |
| August 30, 2024 | Acquisition date of 72 shares under the Issuer's 2015 Employee Stock Purchase Plan |
| September 9, 2024 | Date of the stock sale transaction |
| September 11, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.